Mon May 19 14:00:00 UTC 2025: Okay, here’s a news article based on the provided text, along with a summary:

**Summary:**

Following a tumultuous week for UnitedHealth Group (UNH), marked by a withdrawn outlook, a DOJ investigation into Medicare billing, and the abrupt resignation of former CEO Andrew Witty, key executives, including new CEO Stephen Hemsley and CFO John Rex, have made significant stock purchases. These insider buys, totaling over $31 million, come after a sharp drop in the company’s stock price and suggest a possible vote of confidence in the company’s future despite current headwinds. However, analysts suggest other AI stocks may provide more returns for investors.

**News Article:**

**UnitedHealth Executives Buy Millions in Stock After Tumultuous Week**

**NEW YORK, NY –** In a show of confidence amidst turmoil, UnitedHealth Group (NYSE:UNH) executives, including newly appointed CEO Stephen Hemsley and CFO John Rex, have purchased significant amounts of company stock. The move comes after a challenging week for the healthcare giant, plagued by a withdrawn full-year outlook, a Department of Justice (DOJ) criminal investigation, and the sudden resignation of former CEO Andrew Witty.

According to a Form 4 filing, Stephen Hemsley, who assumed the role of CEO on Tuesday, May 16th, acquired approximately $25 million worth of UNH shares on Friday, May 16th, at an average price of $288.57 per share. CFO John Rex also purchased 17,200 shares on the same day, at $291.12 per share, totaling approximately $5 million.

Prior to Hemsley’s and Rex’s purchases, three other UnitedHealth Group Directors, Tim Flynn, Kristen Gil and John Noseworthy, collectively acquired around $1.6 million worth of UNH shares.

These insider buys follow a sharp decline in UNH’s stock price. Shares tumbled from $307.95 on Wednesday to $274.11 on Thursday after the company withdrew its full-year outlook, a move exacerbated by news of the DOJ’s investigation into the company’s Medicare billing practices. The investigation also triggered the resignation of Witty. UNH stock is down over 42% since the beginning of 2025.

The DOJ’s criminal probe is focused on UnitedHealth Group’s Medicare billing practices, the details of which remain undisclosed.

While the executive stock purchases may signal internal optimism about UnitedHealth’s long-term prospects, some analysts suggest investors consider other AI-driven investments that have the potential for higher returns.

Read More